These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 16713185

  • 1. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
    Buchsbaum MS, Christian BT, Lehrer DS, Narayanan TK, Shi B, Mantil J, Kemether E, Oakes TR, Mukherjee J.
    Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
    [Abstract] [Full Text] [Related]

  • 2. Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task.
    Christian BT, Lehrer DS, Shi B, Narayanan TK, Strohmeyer PS, Buchsbaum MS, Mantil JC.
    Neuroimage; 2006 May 15; 31(1):139-52. PubMed ID: 16469510
    [Abstract] [Full Text] [Related]

  • 3. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
    Landvogt C, Buchholz HG, Bernedo V, Schreckenberger M, Werhahn KJ.
    Epilepsia; 2010 Sep 15; 51(9):1699-706. PubMed ID: 20384765
    [Abstract] [Full Text] [Related]

  • 4. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, Müller-Forell W, Piel M, Rösch F, Glaser M, Schreckenberger M, Bartenstein P.
    Epilepsia; 2006 Aug 15; 47(8):1392-6. PubMed ID: 16922886
    [Abstract] [Full Text] [Related]

  • 5. Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
    Talvik M, Nordström AL, Olsson H, Halldin C, Farde L.
    Int J Neuropsychopharmacol; 2003 Dec 15; 6(4):361-70. PubMed ID: 14604451
    [Abstract] [Full Text] [Related]

  • 6. The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [18F]fallypride.
    Joo YH, Kim JH, Son YD, Kim HK, Shin YJ, Lee SY, Kim JH.
    Eur Arch Psychiatry Clin Neurosci; 2018 Sep 15; 268(6):529-540. PubMed ID: 28623450
    [Abstract] [Full Text] [Related]

  • 7. D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia.
    Vyas NS, Buchsbaum MS, Lehrer DS, Merrill BM, DeCastro A, Doninger NA, Christian BT, Mukherjee J.
    Schizophr Res; 2018 Feb 15; 192():442-456. PubMed ID: 28576546
    [Abstract] [Full Text] [Related]

  • 8. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, Satter M, Mantil J.
    Synapse; 2002 Dec 01; 46(3):170-88. PubMed ID: 12325044
    [Abstract] [Full Text] [Related]

  • 9. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M.
    Synapse; 2009 Jun 01; 63(6):447-61. PubMed ID: 19217025
    [Abstract] [Full Text] [Related]

  • 10. Positive association between cerebral grey matter metabolism and dopamine D2/D3 receptor availability in healthy and schizophrenia subjects: An 18F-fluorodeoxyglucose and 18F-fallypride positron emission tomography study.
    Mitelman SA, Buchsbaum MS, Christian BT, Merrill BM, Buchsbaum BR, Mukherjee J, Lehrer DS.
    World J Biol Psychiatry; 2020 Jun 01; 21(5):368-382. PubMed ID: 31552783
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects.
    Hagelberg N, Aalto S, Kajander J, Oikonen V, Hinkka S, Någren K, Hietala J, Scheinin H.
    Pain; 2004 May 01; 109(1-2):86-93. PubMed ID: 15082129
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Surrogate markers for cerebral blood flow correlate with [¹⁸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum.
    Cumming P, Xiong G, la Fougère C, Rominger A, Bartenstein P, Buchholz HG, Piel M, Rösch F, Gründer G, Vernaleken I.
    Synapse; 2013 Apr 01; 67(4):199-203. PubMed ID: 23239525
    [Abstract] [Full Text] [Related]

  • 16. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
    Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G.
    J Clin Psychopharmacol; 2008 Dec 01; 28(6):608-17. PubMed ID: 19011428
    [Abstract] [Full Text] [Related]

  • 17. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride.
    Kaur J, Khararjian A, Coleman RA, Constantinescu CC, Pan ML, Mukherjee J.
    Nucl Med Biol; 2014 Dec 01; 41(10):841-7. PubMed ID: 25199843
    [Abstract] [Full Text] [Related]

  • 18. The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.
    Christian BT, Vandehey NT, Fox AS, Murali D, Oakes TR, Converse AK, Nickles RJ, Shelton SE, Davidson RJ, Kalin NH.
    Neuroimage; 2009 Feb 15; 44(4):1334-44. PubMed ID: 19015034
    [Abstract] [Full Text] [Related]

  • 19. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET.
    Mukherjee J, Christian BT, Narayanan TK, Shi B, Collins D.
    Brain Res; 2005 Jan 25; 1032(1-2):77-84. PubMed ID: 15680944
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.
    Mukherjee J, Constantinescu CC, Hoang AT, Jerjian T, Majji D, Pan ML.
    Synapse; 2015 Dec 25; 69(12):577-91. PubMed ID: 26422464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.